Loading...
•
Jun 30, 2025
ResMed Q4 2025 Earnings Report
ResMed's Q4 2025 earnings showed strong growth with revenue up 10%, operating profit up 19%, and non-GAAP EPS increasing by 23%.
Key Takeaways
ResMed concluded fiscal year 2025 with a robust fourth quarter, driven by strong global demand for sleep and breathing health devices and an expanding digital health ecosystem. The company achieved double-digit revenue growth and significant improvements in gross margin and earnings per share.
Revenue increased by 10% to $1.348 billion in Q4 2025, demonstrating strong market demand.
Non-GAAP gross margin improved by 230 basis points to 61.4%, reflecting enhanced efficiencies.
Diluted earnings per share (EPS) grew by 30% to $2.58, while non-GAAP diluted EPS increased by 23% to $2.55.
Operating cash flow for the quarter was strong at $539 million, significantly exceeding net income.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
ResMed plans to continue investing in innovation, scaling digital health capabilities, and partnering with stakeholders to expand access to care in fiscal year 2026.
Positive Outlook
- Continued investment in innovation to drive future growth.
- Scaling digital health capabilities to enhance connected care platform.
- Partnerships with patients, providers, payers, and policymakers to expand access to care.
- Focus on market-leading sleep and breathing health devices.
- Empowering millions to manage their health with hardware, software, and healthcare solutions.
Challenges Ahead
- No specific negative forward guidance was provided in the report.
- The report does not detail potential challenges in market competition.
- No mention of potential supply chain disruptions.
- No specific risks related to regulatory changes were highlighted.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...